Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "UK London Duchen MR"

From Bioblast
 
(15 intermediate revisions by 7 users not shown)
Line 1: Line 1:
{{MiPNetLab
{{O2k-Network Lab
|address=[[Duchen M|Duchen Michael]], Prof. Dr.
|institution=Department of Physiology
 
Department of Physiology


University College London
University College London
Gower Street WC1E 6BT
London, United Kingdom
|city=London
|city=London
|country=United Kingdom
|country=United Kingdom
|weblink=[[UCL Consortium for Mitochondrial Research]]
|weblink=[[UCL Consortium for Mitochondrial Research]]
|MiPNetLab=Duchen M, Kotiadis W
|Contact=Duchen Michael R
|MiPNetLab=Briston Thomas, Kotiadis Will, Stanzani Giacomo
|Status=O2k 2012-
|info=[[MiPNet23.03 IOC128 Cambridge UK| IOC128]], organizer of [[MiPschool_London_2015| MiPschool 2015]], [[Bioblast 2012 | Bioblast 2012]]
}}
}}

Latest revision as of 08:21, 2 August 2019

                



UK London Duchen MR

Oroboros O2k-Network

O2k-Network
O2k-Network Lab Department of Physiology

University College London

Address ,
City London
State/Prov
Country United Kingdom
Weblink UCL Consortium for Mitochondrial Research
Contact Duchen Michael R
Team Briston Thomas, Kotiadis Will, Stanzani Giacomo
Team previous
Status O2k 2012-
Oroboros Events IOC128, organizer of MiPschool 2015, Bioblast 2012
Topics


O2k-Publications

 PublishedReference
Saura-Esteller 2021 Int J Mol Sci2021Saura-Esteller J, Sánchez-Vera I, Núñez-Vázquez S, Cosialls AM, Gama-Pérez P, Bhosale G, Mendive-Tapia L, Lavilla R, Pons G, Garcia-Roves PM, Duchen MR, Iglesias-Serret D, Gil J (2021) Activation of the integrated stress response and ER stress protect from fluorizoline-induced apoptosis in HEK293T and U2OS cell lines. Int J Mol Sci 22:6117.
Connolly 2018 Cell Death Differ2018Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, Bolaños JP, Culmsee C, Dawson VL, Deshmukh M, Duchen MR, Düssmann H, Fiskum G, Galindo MF, Hardingham GE, Hardwick JM, Jekabsons MB, Jonas EA, Jordán J, Lipton SA, Manfredi G, Mattson MP, McLaughlin B, Methner A, Murphy AN, Murphy MP, Nicholls DG, Polster BM, Pozzan T, Rizzuto R, Satrústegui J, Slack RS, Swanson RA, Swerdlow RH, Will Y, Ying Z, Joselin A, Gioran A, Moreira Pinho C, Watters O, Salvucci M, Llorente-Folch I, Park DS, Bano D, Ankarcrona M, Pizzo P, Prehn JHM (2018) Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death Differ 25:542-72. https://doi.org/10.1038/s41418-017-0020-4
Corrochano 2018 Hum Mol Genet2018Corrochano S, Blanco G, Williams D, Wettstein J, Simon M, Kumar S, Moir L, Agnew T, Stewart M, Landman A, Kotiadis VN, Duchen MR, Wackerhage H, Rubinsztein DC, Brown SDM, Acevedo-Arozena A (2018) A genetic modifier suggests that endurance exercise exacerbates Huntington's disease. Hum Mol Genet 27:1723-31.
Briston 2017 Sci Rep2017Briston T, Roberts M, Lewis S, Powney B, M Staddon J, Szabadkai G, Duchen MR (2017) Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability. Sci Rep 7:10492.
Selwood 2017 US Patent2017Selwood DL, Baker D, Szabadkai G, Duchen MR, Hill JM, Warne JND (2017) Quinolium conjugates of cyclosporin. US Patent US20170349632 A1.
Briston 2016 Sci Rep2016Briston T, Lewis S, Koglin M, Mistry K, Shen Y, Hartopp N, Katsumata R, Fukumoto H, Duchen MR, Szabadkai G, Staddon JM, Roberts M, Powney B (2016) Identification of ER-000444793, a Cyclophilin D-independent inhibitor of mitochondrial permeability transition, using a high-throughput screen in cryopreserved mitochondria. Sci Rep 6:37798.
MiPNet20.03 IOC101 London2015-04-21
O2k-Network
London UK, 2015 Apr 21-23. Oroboros O2k-Workshop on HRR and O2k-Fluorometry, IOC101.
Warne 2015 J Biol Chem2015Warne J, Pryce G, Hill JM, Shi X, Lennerås F, Puentes F, Kip M, Hilditch L, Walker P, Simone MI, Chan AWE, Towers GJ, Coker AR, Duchen MR, Szabadkai G, Baker D, Selwood DL (2015) Selective inhibition of the mitochondrial permeability transition pore protects against neuro-degeneration in experimental multiple sclerosis. J Biol Chem 291:4356-73.
Corona 2014 Exp Neurol2014Corona JC, de Souza SC, Duchen MR (2014) PPARγ activation rescues mitochondrial function from inhibition of 2 complex I and loss of PINK1. Exp Neurol 253:16-27.
Logan 2014 Nat Genet2014Logan CV, Szabadkai G, Sharpe JA, Parry DA, Torelli S, Childs AM, Kriek M, Phadke R, Johnson CA, Roberts NY, Bonthron DT, Pysden KA, Whyte T, Munteanu I, Foley AR, Wheway G, Szymanska K, Natarajan S, Abdelhamed ZA, Morgan JE, Roper H, Santen GW, Niks EH, van der Pol WL, Lindhout D, Raffaello A, De Stefani D, den Dunnen JT, Sun Y, Ginjaar I, Sewry CA, Hurles M, Rizzuto R. UK10K Consortium, Duchen MR, Muntoni F, Sheridan E (2014) Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nat Genet 46:188-93.

O2k-Abstracts

 PublishedReference
Logan 2015 Abstract MiPschool London 20152015Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signalling.